"Designing Growth Strategies is in our DNA"

Psoriasis Treatment Market Size, Share & Covid-19 Impact Analysis, By Drug Class (TNF inhibitors, Interleukins, and Others), By Type (Plaque Psoriasis, Psoriatic Arthritis, and Others), By Route of Administration (Oral, Parenteral/Systemic, and Topical) By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and Regional Forecast, 2020-2027

Region : Global | Format: PDF | Report ID: FBI100600

 

Table of Content:

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
  4. Key Insights
    1. Prevalence of Psoriasis and Psoriatic Arthritis for Key Countries/Region
    2. Recent Industry Developments Such as Partnerships, Mergers & Acquisitions, New Product Launches Etc.
    3. Pipeline Analysis for Key Companies
    4. Regulatory Framework by Key Countries
    5. Global Reimbursement Scenario
  5. Global Psoriasis Treatment Market Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Drug Class
      1. TNF Inhibitors
      2. Interleukins
      3. Others
    3. Market Analysis, Insights and Forecast – By Type
      1. Plaque Psoriasis
      2. Psoriatic Arthritis
      3. Others
    4. Market Analysis, Insights and Forecast – By Route of Administration
      1. Oral
      2. Parenteral
      3. Topical
    5. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online pharmacies
    6. Market Analysis, Insights and Forecast – By Region
      1. North America
      2. Europe
      3. Asia pacific
      4. Latin America
      5. Middle East & Africa
  6. North America Psoriasis Treatment Market Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary
    2. Market Analysis – By Drug Class
      1. TNF Inhibitors
      2. Interleukins
      3. Others
    3. Market Analysis – By Type
      1. Plaque Psoriasis
      2. Psoriatic Arthritis
      3. Others
    4. Market Analysis – By Route of Administration
      1. Oral
      2. Parenteral
      3. Topical
    5. Market Analysis – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online pharmacies
    6. Market Analysis – By Country/Sub-region
      1. U.S.
      2. Canada
  7. Asia Pacific Psoriasis Treatment Market Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary
    2. Market Analysis – By Drug Class
      1. TNF Inhibitors
      2. Interleukins
      3. Others
    3. Market Analysis – By Type
      1. Plaque Psoriasis
      2. Psoriatic Arthritis
      3. Others
    4. Market Analysis – By Route of Administration
      1. Oral
      2. Parenteral
      3. Topical
    5. Market Analysis – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online pharmacies
    6. Market Analysis – By Country/Sub-region
      1. Japan
      2. China
      3. India
      4. Australia
      5. Southeast Asia
      6. Rest of Asia Pacific
  8. Europe Psoriasis Treatment Market Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary
    2. Market Analysis – By Drug Class
      1. TNF Inhibitors
      2. Interleukins
      3. Others
    3. Market Analysis – By Type
      1. Plaque Psoriasis
      2. Psoriatic Arthritis
      3. Others
    4. Market Analysis – By Route of Administration
      1. Oral
      2. Parenteral
      3. Topical
    5. Market Analysis – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online pharmacies
    6. Market Analysis – By Country/Sub-region
      1. U.K.
      2. Germany
      3. France
      4. Spain
      5. Italy
      6. Scandinavia
      7. Rest of Europe
  9. Latin America Psoriasis Treatment Market Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary
    2. Market Analysis – By Drug Class
      1. TNF Inhibitors
      2. Interleukins
      3. Others
    3. Market Analysis – By Type
      1. Plaque Psoriasis
      2. Psoriatic Arthritis
      3. Others
    4. Market Analysis – By Route of Administration
      1. Oral
      2. Parenteral
      3. Topical
    5. Market Analysis – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online pharmacies
    6. Market Analysis – By Country/Sub-region
      1. Brazil
      2. Mexico
      3. Rest of Latin America
  10. Middle East & Africa Psoriasis Treatment Market Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary
    2. Market Analysis – By Drug Class
      1. TNF Inhibitors
      2. Interleukins
      3. Others
    3. Market Analysis – By Type
      1. Plaque Psoriasis
      2. Psoriatic Arthritis
      3. Others
    4. Market Analysis – By Route of Administration
      1. Oral
      2. Parenteral
      3. Topical
    5. Market Analysis – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online pharmacies
    6. Market Analysis – By Country/Sub-region
      1. GCC Countries
      2. South Africa
      3. Rest of Middle East & Africa
  11. Competitive Analysis
    1. Key Industry Developments
    2. Global Market Share Analysis (2019)
    3. Competition Dashboard
    4. Comparative Analysis – Major Players
    5. Company Profiles (Overview, Products & services, SWOT analysis, Recent developments, strategies, financials (based on availability))
      1. AbbVie Inc.
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      2. Novartis AG
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      3. Johnson & Johnson Services, Inc.
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      4. Pfizer Inc.,
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      5. LEO Pharma A/S
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      6. Merck & Co., Inc.
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      7. Amgen Inc.
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      8. Eli Lilly and Company
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      9. CELGENE CORPORATION
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      10. UCB S.A.
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      11. Sun Pharmaceutical Industries Ltd.
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      12. Other prominent players
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
  12. Strategic Recommendations

List of Figures

Figure 1:  Global Psoriasis Treatment Market Revenue Breakdown (US$ Bn, %) by Region, 2019 & 2027

Figure 2:  Global Psoriasis Treatment Market Value Share (%), by Drug Class, 2019 & 2027

Figure 3:  Global Psoriasis Treatment Market Forecast (US$ Bn), by TNF Inhibitors, 2016-2027

Figure 4:  Global Psoriasis Treatment Market Forecast (US$ Bn), by Interleukins, 2016-2027

Figure 5:  Global Psoriasis Treatment Market Forecast (US$ Bn), by Others, 2016-2027

Figure 6:  Global Psoriasis Treatment Market Value Share (%), by Type, 2019 & 2027

Figure 7:  Global Psoriasis Treatment Market Forecast (US$ Bn), by Plaque Psoriasis, 2016-2027

Figure 8:  Global Psoriasis Treatment Market Forecast (US$ Bn), by Psoriatic Arthritis, 2016-2027

Figure 9:  Global Psoriasis Treatment Market Forecast (US$ Bn), by Others, 2016-2027

Figure 10:  Global Psoriasis Treatment Market Value Share (%), by Route of Administration, 2019 & 2027

Figure 11:  Global Psoriasis Treatment Market Forecast (US$ Bn), by Oral, 2016-2027

Figure 12:  Global Psoriasis Treatment Market Forecast (US$ Bn), by Parenteral, 2016-2027

Figure 13:  Global Psoriasis Treatment Market Forecast (US$ Bn), by Topical, 2016-2027

Figure 14:  Global Psoriasis Treatment Market Value Share (%), by Distribution Channel, 2019 & 2027

Figure 15:  Global Psoriasis Treatment Market Forecast (US$ Bn), by Hospital Pharmacies, 2016-2027

Figure 16:  Global Psoriasis Treatment Market Forecast (US$ Bn), by Retail Pharmacies, 2016-2027

Figure 17:  Global Psoriasis Treatment Market Forecast (US$ Bn), by Online Pharmacies, 2016-2027

Figure 18:  Global Psoriasis Treatment Market Value (US$ Bn), by Region, 2019 & 2027

Figure 19:  North America Psoriasis Treatment Market Value (US$ Bn), by Drug Class, 2019 & 2027

Figure 20:  North America Psoriasis Treatment Market Value Share (%), by Drug Class, 2019

Figure 21:  North America Psoriasis Treatment Market Value (US$ Bn), by Type, 2019 & 2027

Figure 22:  North America Psoriasis Treatment Market Value Share (%), by Type, 2019

Figure 23:  North America Psoriasis Treatment Market Value (US$ Bn), by Route of Administration, 2019 & 2027

Figure 24:  North America Psoriasis Treatment Market Value Share (%), by Route of Administration, 2019

Figure 25:  North America Psoriasis Treatment Market Value (US$ Bn), by Distribution Channel, 2019 & 2027

Figure 26:  North America Psoriasis Treatment Market Value Share (%), by Distribution Channel, 2019

Figure 27:  North America Psoriasis Treatment Market Value (US$ Bn), By Country, 2019 & 2027

Figure 28:  North America Psoriasis Treatment Market Value Share (%), By Country, 2019

Figure 29:  Europe Psoriasis Treatment Market Value (US$ Bn), by Drug Class, 2019 & 2027

Figure 30:  Europe Psoriasis Treatment Market Value Share (%), by Drug Class, 2019

Figure 31:  Europe Psoriasis Treatment Market Value (US$ Bn), by Type, 2019 & 2027

Figure 32:  Europe Psoriasis Treatment Market Value Share (%), by Type, 2019

Figure 33:  Europe Psoriasis Treatment Market Value (US$ Bn), by Route of Administration, 2019 & 2027

Figure 34:  Europe Psoriasis Treatment Market Value Share (%), by Route of Administration, 2019

Figure 35:  Europe Psoriasis Treatment Market Value (US$ Bn), by Distribution Channel, 2019 & 2027

Figure 36:  Europe Psoriasis Treatment Market Value Share (%), by Distribution Channel, 2019

Figure 37:  Europe Psoriasis Treatment Market Value (US$ Bn), By Country/ Sub-region, 2019 & 2027

Figure 38:  Europe Psoriasis Treatment Market Value Share (%), By Country/ Sub-region, 2019

Figure 39:  Asia Pacific Psoriasis Treatment Market Value (US$ Bn), by Drug Class, 2019 & 2027

Figure 40:  Asia Pacific Psoriasis Treatment Market Value Share (%), by Drug Class, 2019

Figure 41:  Asia Pacific Psoriasis Treatment Market Value (US$ Bn), by Type, 2019 & 2027

Figure 42:  Asia Pacific Psoriasis Treatment Market Value Share (%), by Type, 2019

Figure 43:  Asia Pacific Psoriasis Treatment Market Value (US$ Bn), by Route of Administration, 2019 & 2027

Figure 44:  Asia Pacific Psoriasis Treatment Market Value Share (%), by Route of Administration, 2019

Figure 45:  Asia Pacific Psoriasis Treatment Market Value (US$ Bn), by Distribution Channel, 2019 & 2027

Figure 46:  Asia Pacific Psoriasis Treatment Market Value Share (%), by Distribution Channel, 2019

Figure 47:  Asia Pacific Psoriasis Treatment Market Value (US$ Bn), By Country/ Sub-region, 2019 & 2027

Figure 48:  Asia Pacific Psoriasis Treatment Market Value Share (%), By Country/ Sub-region, 2019

Figure 49:  Latin America Psoriasis Treatment Market Value (US$ Bn), by Drug Class, 2019 & 2027

Figure 50:  Latin America Psoriasis Treatment Market Value Share (%), by Drug Class, 2019

Figure 51:  Latin America Psoriasis Treatment Market Value (US$ Bn), by Type, 2019 & 2027

Figure 52:  Latin America Psoriasis Treatment Market Value Share (%), by Type, 2019

Figure 53:  Latin America Psoriasis Treatment Market Value (US$ Bn), by Route of Administration, 2019 & 2027

Figure 54:  Latin America Psoriasis Treatment Market Value Share (%), by Route of Administration, 2019

Figure 55:  Latin America Psoriasis Treatment Market Value (US$ Bn), by Distribution Channel, 2019 & 2027

Figure 56:  Latin America Psoriasis Treatment Market Value Share (%), by Distribution Channel, 2019

Figure 57:  Latin America Psoriasis Treatment Market Value (US$ Bn), By Country/ Sub-region, 2019 & 2027

Figure 58:  Latin America Psoriasis Treatment Market Value Share (%), By Country/ Sub-region, 2019

Figure 59:  Middle East & Africa Psoriasis Treatment Market Value (US$ Bn), by Drug Class, 2019 & 2027

Figure 60:  Middle East & Africa Psoriasis Treatment Market Value Share (%), by Drug Class, 2019

Figure 61:  Middle East & Africa Psoriasis Treatment Market Value (US$ Bn), by Type, 2019 & 2027

Figure 62:  Middle East & Africa Psoriasis Treatment Market Value Share (%), by Type, 2019

Figure 63:  Middle East & Africa Psoriasis Treatment Market Value (US$ Bn), by Route of Administration, 2019 & 2027

Figure 64:  Middle East & Africa Psoriasis Treatment Market Value Share (%), by Route of Administration, 2019

Figure 65:  Middle East & Africa Psoriasis Treatment Market Value (US$ Bn), by Distribution Channel, 2019 & 2027

Figure 66:  Middle East & Africa Psoriasis Treatment Market Value Share (%), by Distribution Channel, 2019

Figure 67:  Middle East & Africa Psoriasis Treatment Market Value (US$ Bn), By Country/ Sub-region, 2019 & 2027

Figure 68:  Middle East & Africa Psoriasis Treatment Market Value Share (%), By Country/ Sub-region, 2019

Figure 69:  Global Psoriasis Treatment Market Share (%), By Company, 2019

List of Tables

Table 1:  Global Psoriasis Treatment Market Revenue (US$ Bn) Forecast, by Drug Class, 2016–2027

Table 2:  Global Psoriasis Treatment Market Revenue (US$ Bn) Forecast, by Type, 2016–2027

Table 3:  Global Psoriasis Treatment Market Revenue (US$ Bn) Forecast, by Route of Administration, 2016–2027

Table 4:  Global Psoriasis Treatment Market Revenue (US$ Bn) Forecast, by Distribution Channel, 2016–2027

Table 5:  Global Psoriasis Treatment Market Revenue (US$ Bn) Forecast, by Region, 2016-2027

Table 6:  North America Psoriasis Treatment Market Revenue (US$ Bn) Forecast, by Drug Class, 2016-2027

Table 7:  North America Psoriasis Treatment Market Revenue (US$ Bn) Forecast, by Type, 2016-2027

Table 8:  North America Psoriasis Treatment Market Revenue (US$ Bn) Forecast, by Route of Administration, 2016-2027

Table 9:  North America Psoriasis Treatment Market Revenue (US$ Bn) Forecast, by Distribution Channel, 2016-2027

Table 10:  North America Psoriasis Treatment Market Revenue (US$ Bn) Forecast, By Country, 2016-2027

Table 11:  Europe Psoriasis Treatment Market Revenue (US$ Bn) Forecast, by Drug Class, 2016-2027

Table 12:  Europe Psoriasis Treatment Market Revenue (US$ Bn) Forecast, by Type, 2016-2027

Table 13:  Europe Psoriasis Treatment Market Revenue (US$ Bn) Forecast, by Route of Administration, 2016-2027

Table 14:  Europe Psoriasis Treatment Market Revenue (US$ Bn) Forecast, by Distribution Channel, 2016-2027

Table 15:  Europe Psoriasis Treatment Market Revenue (US$ Bn) Forecast, By Country/ Sub-region, 2016-2027

Table 16:  Asia Pacific Psoriasis Treatment Market Revenue (US$ Bn) Forecast, by Drug Class, 2016-2027

Table 17:  Asia Pacific Psoriasis Treatment Market Revenue (US$ Bn) Forecast, by Type, 2016-2027

Table 18:  Asia Pacific Psoriasis Treatment Market Revenue (US$ Bn) Forecast, by Route of Administration, 2016-2027

Table 19:  Asia Pacific Psoriasis Treatment Market Revenue (US$ Bn) Forecast, by Distribution Channel, 2016-2027

Table 20:  Asia Pacific Psoriasis Treatment Market Revenue (US$ Bn) Forecast, By Country/ Sub-region, 2016-2027

Table 21:  Latin America Psoriasis Treatment Market Revenue (US$ Bn) Forecast, by Drug Class, 2016-2027

Table 22:  Latin America Psoriasis Treatment Market Revenue (US$ Bn) Forecast, by Type, 2016-2027

Table 23:  Latin America Psoriasis Treatment Market Revenue (US$ Bn) Forecast, by Route of Administration, 2016-2027

Table 24:  Latin America Psoriasis Treatment Market Revenue (US$ Bn) Forecast, by Distribution Channel, 2016-2027

Table 25:  Latin America Psoriasis Treatment Market Revenue (US$ Bn) Forecast, By Country/ Sub-region, 2016-2027

Table 26:  Middle East & Africa Psoriasis Treatment Market Revenue (US$ Bn) Forecast, by Drug Class, 2016-2027

Table 27:  Middle East & Africa Psoriasis Treatment Market Revenue (US$ Bn) Forecast, by Type, 2016-2027

Table 28:  Middle East & Africa Psoriasis Treatment Market Revenue (US$ Bn) Forecast, by Route of Administration, 2016-2027

Table 29:  Middle East & Africa Psoriasis Treatment Market Revenue (US$ Bn) Forecast, by Distribution Channel, 2016-2027

Table 30:  Middle East & Africa Psoriasis Treatment Market Revenue (US$ Bn) Forecast, By Country/ Sub-region, 2016-2027

 class=
  • Jul, 2020
  • 2019
  • 2016-2018
  • 155

    CHOOSE LICENSE TYPE

  • 4850
    6850
    8850

Healthcare Clients

3M
abbvie
Amgen
Ansell
Fresenius
Galemed
Grifols
Ipsos
iqvia
Johnson
Jubilant
Lek
Pfizer
Roche
Siemens Healthineers
Styker
uniliver

Client Testimonials

“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”

- One of the Leading Food Companies in Germany

“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”

- Intuitive Surgical

“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”

- Major Food Company in Japan

“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”

- Ziering Medical

“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”

- Major Manufacturer of Precision Machine Parts in India

“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”

- Hewlett-Packard

“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”

- Global Management Consulting Firm

“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”

- UK-based Start-up in the Medical Devices Sector

“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”

- One of the Largest Companies in the Defence Industry
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . Privacy.
X